These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9075807)

  • 1. Nitric oxide and ocular blood flow in patients with IDDM.
    Schmetterer L; Findl O; Fasching P; Ferber W; Strenn K; Breiteneder H; Adam H; Eichler HG; Wolzt M
    Diabetes; 1997 Apr; 46(4):653-8. PubMed ID: 9075807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ocular hemodynamic response to nitric oxide synthase inhibition is unaltered in patients with early type I diabetes.
    Dorner GT; Garhöfer G; Selenko N; Fasching P; Bayerle-Eder M; Schmetterer L; Wolzt M
    Graefes Arch Clin Exp Ophthalmol; 2003 Aug; 241(8):619-24. PubMed ID: 12836035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of systemic nitric oxide-synthase inhibition on ocular fundus pulsations in man.
    Schmetterer L; Krejcy K; Kastner J; Wolzt M; Gouya G; Findl O; Lexer F; Breiteneder H; Fercher AF; Eichler HG
    Exp Eye Res; 1997 Mar; 64(3):305-12. PubMed ID: 9196381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of NO in the O2 and CO2 responsiveness of cerebral and ocular circulation in humans.
    Schmetterer L; Findl O; Strenn K; Graselli U; Kastner J; Eichler HG; Wolzt M
    Am J Physiol; 1997 Dec; 273(6):R2005-12. PubMed ID: 9435655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of adrenomedullin on ocular hemodynamic parameters in the choroid and the ophthalmic artery.
    Dorner GT; Garhöfer G; Huemer KH; Golestani E; Zawinka C; Schmetterer L; Wolzt M
    Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3947-51. PubMed ID: 12939313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of systemic NO synthase inhibition on choroidal and optic nerve head blood flow in healthy subjects.
    Luksch A; Polak K; Beier C; Polska E; Wolzt M; Dorner GT; Eichler HG; Schmetterer L
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3080-4. PubMed ID: 10967067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal and ocular hemodynamic effects of insulin.
    Schmetterer L; Müller M; Fasching P; Diepolder C; Gallenkamp A; Zanaschka G; Findl O; Strenn K; Mensik C; Tschernko E; Eichler HG; Wolzt M
    Diabetes; 1997 Nov; 46(11):1868-74. PubMed ID: 9356038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetazolamide-induced cerebral and ocular vasodilation in humans is independent of nitric oxide.
    Kiss B; Dallinger S; Findl O; Rainer G; Eichler HG; Schmetterer L
    Am J Physiol; 1999 Jun; 276(6):R1661-7. PubMed ID: 10362745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic-pharmacodynamic profile of systemic nitric oxide-synthase inhibition with L-NMMA in humans.
    Mayer BX; Mensik C; Krishnaswami S; Derendorf H; Eichler HG; Schmetterer L; Wolzt M
    Br J Clin Pharmacol; 1999 May; 47(5):539-44. PubMed ID: 10336578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic and sympathetic effects of inhibition of nitric oxide synthase by systemic infusion of N(G)-monomethyl-L-arginine into humans are dose dependent.
    Lepori M; Sartori C; Trueb L; Owlya R; Nicod P; Scherrer U
    J Hypertens; 1998 Apr; 16(4):519-23. PubMed ID: 9797197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered nitric oxide system in patients with open-angle glaucoma.
    Polak K; Luksch A; Berisha F; Fuchsjaeger-Mayrl G; Dallinger S; Schmetterer L
    Arch Ophthalmol; 2007 Apr; 125(4):494-8. PubMed ID: 17420369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF.
    Tilton RG; Chang KC; LeJeune WS; Stephan CC; Brock TA; Williamson JR
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):689-96. PubMed ID: 10067972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasodilator responses in the forearm skin of patients with insulin-dependent diabetes mellitus.
    Khan F; Cohen RA; Ruderman NB; Chipkin SR; Coffman JD
    Vasc Med; 1996; 1(3):187-93. PubMed ID: 9546937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of nitric oxide to the blood pressure and arterial responses to exercise in humans.
    Campbell R; Fisher JP; Sharman JE; McDonnell BJ; Frenneaux MP
    J Hum Hypertens; 2011 Apr; 25(4):262-70. PubMed ID: 20505750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dose-response study of nitric oxide synthase inhibition in different vascular beds in man.
    Hjorth Lassen L; Klingenberg Iversen H; Olesen J
    Eur J Clin Pharmacol; 2003 Oct; 59(7):499-505. PubMed ID: 13680036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of local vascular effects of the nitric oxide inhibitor NG-monomethyl-L-arginine on dorsal hand veins.
    Schindler C; Leuschner S; Schwanebeck U; Kirch W
    J Clin Pharmacol; 2012 Jun; 52(6):859-69. PubMed ID: 21566204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of NO in the control of choroidal blood flow during a decrease in ocular perfusion pressure.
    Simader C; Lung S; Weigert G; Kolodjaschna J; Fuchsjäger-Mayrl G; Schmetterer L; Polska E
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):372-7. PubMed ID: 19124845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nitric oxide synthase inhibition on renal hemodynamics in humans: reversal by L-arginine.
    Wolzt M; Schmetterer L; Ferber W; Artner E; Mensik C; Eichler HG; Krejcy K
    Am J Physiol; 1997 Feb; 272(2 Pt 2):F178-82. PubMed ID: 9124393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of NO in choroidal blood flow regulation during isometric exercise in healthy humans.
    Luksch A; Polska E; Imhof A; Schering J; Fuchsjäger-Mayrl G; Wolzt M; Schmetterer L
    Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):734-9. PubMed ID: 12556406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-peptide does not affect ocular blood flow in patients with type 1 diabetes.
    Polska E; Kolodjaschna J; Berisha F; Malec MM; Simader C; Bayerle-Eder M; Roden M; Schmetterer L
    Diabetes Care; 2006 Sep; 29(9):2034-8. PubMed ID: 16936149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.